SAN DIEGO--(BUSINESS WIRE)--Iapyx Medical™, a developer of innovative medical devices, today announced a $9 million investment by Tavistock Life Sciences, bringing the Company’s total funding to more than $12 million. This round of funding coincides with the Company’s rebranding from Medical Device Group to Iapyx Medical, and its new mission to develop innovative medical devices that reduce hospital-acquired infections. Iapyx plans to use this round of funding to support product development, marketing and sales.
